Page last updated: 2024-10-24

carbamazepine and Bone Loss, Perimenopausal

carbamazepine has been researched along with Bone Loss, Perimenopausal in 1 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Research Excerpts

ExcerptRelevanceReference
"Secondary osteoporosis is the major concern associated with long term intake of antiepileptic drugs (AEDs)."1.48The anti-epileptic drugs valproate, carbamazepine and levetiracetam cause bone loss and modulate Wnt inhibitors in normal and ovariectomised rats. ( Chattopadhyay, N; Jain, M; Pal, S; Parveen, B; Tiwari, AK; Tripathi, M; Vohora, D, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parveen, B1
Tiwari, AK1
Jain, M1
Pal, S1
Chattopadhyay, N1
Tripathi, M1
Vohora, D1

Other Studies

1 other study available for carbamazepine and Bone Loss, Perimenopausal

ArticleYear
The anti-epileptic drugs valproate, carbamazepine and levetiracetam cause bone loss and modulate Wnt inhibitors in normal and ovariectomised rats.
    Bone, 2018, Volume: 113

    Topics: Animals; Anticonvulsants; Bone and Bones; Bone Density; Carbamazepine; Female; Humans; Levetiracetam

2018